Colon Cancer Symptoms - Nektar’s Clinical Trial To Evaluate NKTR-102 Efficacy In Colorectal
Nektar’s Clinical Trial To Evaluate NKTR-102 Efficacy In Colorectal
eMaxHealth.com - Nektar Therapeutics starts Phase 2 clinical development program to evaluate NKTR-102 (PEG-irinotecan) as a potential treatment for colorectal cancer. ASGE encourages all men and women age 50 and over to add getting screened for colorectal cancer to
Mazurek s colon cancer screening bill OK d by state panel
MaineCoastNow.com - According to the American Cancer Society, almost 300 Maine people died from colon cancer last year. Routine screening for people over 50 years of age can significantly reduce the incidence of colon cancer, and early treatment can greatly reduce
Roche 2007 Profit Rises 25% on Sales of Cancer Drugs (Update1)
Bloomberg - Avastin for colon cancer and the Herceptin breast tumor treatment are helping Roche grow faster than rivals such as Novartis AG who face competition from generic medicines. Roche is testing treatments developed with Genentech Inc. against more tumor
Roche 2007 Profit Rises on Sales of Cancer Medicines (Update3)
Bloomberg - Avastin for colon cancer and the Herceptin breast tumor treatment are helping Roche grow faster than rivals, such as Novartis AG, who face competition from generic medicines. Roche is testing treatments developed with Genentech Inc. against more